Mary Ann Orr, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 401 W Grove St, Dunmore, PA 18510 Phone: 570-346-8770 |
Ellen Butash, Registered Nurse - Emergency Medicare: Not Enrolled in Medicare Practice Location: 1000 Dunham Dr, Dunmore, PA 18512 Phone: 570-687-0589 |
Mary Vitale, Registered Nurse - Emergency Medicare: Not Enrolled in Medicare Practice Location: 1000 Dunham Dr, Dunmore, PA 18512 Phone: 570-687-0589 |
Mrs. Linda Jean West, RN Registered Nurse - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1141 Clay Ave, Dunmore, PA 18510 Phone: 570-346-3686 |
News Archive
A recent study suggests that obese people with metabolic syndrome face an unexpected quandary when it comes to vitamin E - they need more than normal levels of the vitamin because their weight and other problems are causing increased oxidative stress, but those same problems actually cause their effective use of vitamin E to be reduced.
The elderly who suffer from dementia aren't able to say when something hurts or is sore. They may demonstrate their pain through behaviours like rocking or striking out, and we often dismiss these actions as symptoms of the dementia instead of pain, which is usually from a different problem. Arthritis, diabetic neuropathy, fractures, muscular contractures, bruises, abdominal pain and mouth ulcers are among the list of common ailments that go undetected.
Eisai Inc. and Arena Pharmaceuticals, Inc. today announced the completion of two Phase 1 registrational clinical trials that Eisai and Arena believe demonstrate bioequivalence of an investigational once-daily extended release formulation of lorcaserin, as compared to the twice-daily immediate release formulation approved by the US Food and Drug Administration and marketed as BELVIQ.
Scientists at Columbia University Medical Center have identified a factor in liver cells that is responsible for turning a relatively benign liver condition, present in 30 percent of U.S. adults, into a serious disease that can lead to liver failure.
An FDA panel decided Thursday that two popular birth control pills should come with stronger warning labels about the possibility of blood clots.
› Verified 3 days ago